Tiribelli C

Language: English
References: 0
Page: 107
PDF size: 22.26 Kb.

Text Extraction

Peg Interferon alfa-2a plus Ribavirin Bosques-Padilla F et al. This study reports the data obtained in a limited number of Mexican patients enrolled in a much larger, multicenter study aimed to test the efficacy of combined treatment (Peg Interferon Alfa-2a plus Ribavirin) in the sustained response in HCV patient. A total 32 subjects were enrolled. Not surprisingly and fully confirmatory of the results obtained in previous series already reported, the overall sustained response (undetectable HCV RNA 6 months after the start of the treatment) was higher (54 vs. 33%) in patients receiving Peg Interferon alfa-2a as compared with those treated interferon Alfa-2b.